ImportRefusal LogoImportRefusal

Divya Pharmacy

⚠️ High Risk

FEI: 3007846706 • Hardwar, Uttarakhand • INDIA

FEI

FEI Number

3007846706

📍

Location

Hardwar, Uttarakhand

🇮🇳

Country

INDIA
🏢

Address

A - 1 Industrial Area, Plot No, Hardwar, Uttarakhand, India

High Risk

FDA Import Risk Assessment

74.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

72
Total Refusals
14
Unique Violations
12/9/2025
Latest Refusal
1/6/2009
Earliest Refusal

Score Breakdown

Violation Severity
75.5×40%
Refusal Volume
69.0×30%
Recency
98.1×20%
Frequency
42.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7560×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1188×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4887×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

32805×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

4824×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

34002×

PB-FOOD

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to contain a poisonous or deleterious substance, lead, which may render it injurious to health.

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

23002×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

31201×

EPHEDALK

The product is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a dietary supplement or a dietary ingredient that appears to contain ephedrine alkaloids, which presents an unreasonable risk of illness or injury under the conditions of use recommended or suggested in the labeling, or if no conditions of use are suggested in the labeling, under ordinary conditions of use.

3211×

LACKS N/C

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

2181×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

Refusal History

DateProductViolationsDivision
12/9/2025
54FGA88GYMNEMA SYLVESTRE (HERBAL & BOTANICALS, NOT TEAS)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/24/2025
21CCT99MIXED FRUIT, JAM, JELLY, PRESERVES, MARMALADE, BUTTER OR CANDIED, N.E.C.
321LACKS N/C
482NUTRIT LBL
Division of Northeast Imports (DNEI)
7/10/2025
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of West Coast Imports (DWCI)
7/10/2025
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of West Coast Imports (DWCI)
4/22/2025
54FDY94ASHWAGANDHA (HERBAL & BOTANICALS, NOT TEAS)
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/25/2025
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/12/2024
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
471CSTIC LBLG
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
471CSTIC LBLG
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
6/6/2024
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Northeast Imports (DNEI)
11/9/2023
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDE99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDR99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/9/2023
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/27/2023
66VBY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/6/2022
64CDA99EMETIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/2/2021
66VAA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/3/2021
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/5/2020
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/5/2020
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/5/2020
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2020
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2020
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2020
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/3/2020
62CBC99ANTI-HYPERTENSIVE N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/11/2019
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Northeast Imports (DNEI)
9/9/2016
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
2/23/2016
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
482NUTRIT LBL
Division of Northeast Imports (DNEI)
7/6/2015
60LBL99ANALGESIC, N.E.C.
118NOT LISTED
16DIRECTIONS
75UNAPPROVED
San Francisco District Office (SAN-DO)
10/1/2014
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3400PB-FOOD
Southwest Import District Office (SWI-DO)
10/1/2014
54FCA99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
3400PB-FOOD
Southwest Import District Office (SWI-DO)
10/26/2011
54FCR99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
218LIST INGRE
2300DIETARYLBL
3120EPHEDALK
324NO ENGLISH
482NUTRIT LBL
75UNAPPROVED
New England District Office (NWE-DO)
6/20/2011
62GCA99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAA99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAA99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAA99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2011
62GAZ99ANTI-INFLAMMATORY N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/13/2010
54FCH99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
473LABELING
482NUTRIT LBL
Atlanta District Office (ATL-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
8/6/2010
54FCT99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
488HEALTH C
Los Angeles District Office (LOS-DO)
1/6/2009
66VDR99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Divya Pharmacy's FDA import refusal history?

Divya Pharmacy (FEI: 3007846706) has 72 FDA import refusal record(s) in our database, spanning from 1/6/2009 to 12/9/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Divya Pharmacy's FEI number is 3007846706.

What types of violations has Divya Pharmacy received?

Divya Pharmacy has been cited for 14 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Divya Pharmacy come from?

All FDA import refusal data for Divya Pharmacy is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.